The U.S. Securities and Exchange Commission hit Baxter International with an $18 million penalty over accounting improprieties that caused the company to misstate its net income.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,